Regeneron Pharmaceuticals, Inc. (REGN)
827.72
-15.75
(-1.87%)
USD |
NASDAQ |
Sep 04, 16:00
828.01
+0.29
(+0.04%)
After-Hours: 20:00
Regeneron Pharmaceuticals Cash and Short Term Investments (Annual) : 8.611B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.611B |
| December 31, 2024 | 9.012B |
| December 31, 2023 | 10.84B |
| December 31, 2022 | 7.742B |
| December 31, 2021 | 5.695B |
| December 31, 2020 | 3.587B |
| December 31, 2019 | 3.214B |
| December 31, 2018 | 2.810B |
| December 31, 2017 | 1.410B |
| December 31, 2016 | 1.039B |
| December 31, 2015 | 1.045B |
| December 31, 2014 | 900.48M |
| December 31, 2013 | 693.98M |
| December 31, 2012 | 308.10M |
| December 31, 2011 | 526.94M |
| December 31, 2010 | 249.37M |
| December 31, 2009 | 341.33M |
| December 31, 2008 | 474.75M |
| Date | Value |
|---|---|
| December 31, 2007 | 766.46M |
| December 31, 2006 | 459.28M |
| December 31, 2005 | 298.54M |
| December 31, 2004 | 295.98M |
| December 31, 2003 | 293.77M |
| December 31, 2002 | 264.27M |
| December 31, 2001 | 385.08M |
| December 31, 2000 | 117.61M |
| December 31, 1999 | 66.16M |
| December 31, 1998 | 85.78M |
| December 31, 1997 | 92.52M |
| December 31, 1996 | 80.06M |
| December 31, 1995 | 46.15M |
| December 31, 1994 | 49.88M |
| December 31, 1993 | 88.28M |
| December 31, 1992 | 83.34M |
| December 31, 1991 | 104.29M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| AbbVie, Inc. | 5.257B |
| Gilead Sciences, Inc. | 9.613B |
| Amgen, Inc. | 9.129B |
| Biogen, Inc. | 3.816B |